Pharmaceutical formulation containing dye
US7214385B2 · kind B2 · utility
74Cited by
12References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 4, 2004 |
| Grant date | May 8, 2007 |
| Priority date | — |
| Expiry date | Jun 29, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5078
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for preventing abuse of dosage forms comprising an opioid analgesic and an aversive agent (e.g., a dye) in an effective amount to deter an abuser from administering a tampered form of the dosage form intravenously, intranasally, and/or orally are revealed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.